National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)

Department Of Health And Human Services
CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC)

NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES, (CR)

Level 1: Office of the Director, (C,R,1)

Level 2: Division of Foodborne, Waterborne and Environmental Diseases, (C,R,B)

  • Level 3: Enteric Diseases Epidemiology Branch, (C,R,B,B)
  • Level 3: Enteric Diseases Laboratory Branch, (C,R,B,C)
  • Level 3: Outbreak Response and Prevention Branch, (C,R,B,D)
  • Level 3: Waterborne Disease Prevention Branch, (C,R,B,E)
  • Level 3: Mycotic Disease Branch, (C,R,B,G)

Level 2: Division of Global Migration and Quarantine, (C,R,C)

  • Level 3: Travel Risk Assessment and Mitigation Branch, (C,R,C,B)
  • Level 3: Immigrant and Refugee Health Branch, (C,R,C,C)
  • Level 3: Travelers’ Health Branch, (C,R,C,D)
  • Level 3: Port Health Protection Branch, (C,R,C,E)
  • Level 3: Southern Border Health and Migration Branch, (C,R,C,G)

Level 2: Division of Healthcare Quality Promotion, (C,R,D)

  • Level 2.1: International Infection Control Activity, (C,R,D,1,2)
  • Level 3: Immunization Safety Office, (C,R,D,B)
  • Level 3: Clinical and Environmental Microbiology Branch, ( C, R, D, C )
  • Level 3: Prevention and Response Branch, (C,R,D,D)
  • Level 3: Surveillance Branch, (C,R,D,E)
  • Level 3: Epidemiology Research and Innovations Branch, (C,R,D,G)
  • Level 3: Healthcare Systems Strengthening, Resilience, and Training Branch, (C,R,D,H)
  • Level 3: International Infection Control Branch, (C,R,D,J)
  • Level 3: Medical Product Safety Branch, (C,R D,K)

Level 2: Division of High-Consequence Pathogens and Pathology, (C,R,E)

  • Level 2.1: Prion and Public Health Office , (C,R,E,1,2)
  • Level 3: Viral Special Pathogens Branch, (C,R,E,B)
  • Level 3: Poxvirus and Rabies Branch, (C,R,E,C)
  • Level 3: Infectious Diseases Pathology Branch, (C,R,E,D)
  • Level 3: Chronic Viral Diseases Branch, (C,R,E,E)
  • Level 3: Bacterial Special Pathogens Branch, (C,R,E,G)

Level 2: Division of Infectious Disease Readiness and Innovation, (C,R,G)

  • Level 3: Arctic Investigations Program, (C,R,G,B)
  • Level 3: Epidemiology Laboratory Capacity and Informatics Branch, (C,R,G,C)
  • Level 3: Rapid Response Research and Surveillance Branch, (C,R,G,D)
  • Level 3: Office of Advanced Molecular Detection, (C,R,G,E)

Level 2: Division of Core Laboratory Services and Response, (C,R,H)

  • Level 3: Advanced Diagnostics and Biotechnologies Branch, (C,R,H,B)
  • Level 3: Comparative Medicine Branch, (C,R,H,C)
  • Level 3: Preparedness, Response, and Outbreak Services Branch, (C,R,H,D)
  • Level 3: Laboratory Products and Services Branch, (C,R,H,E)

Level 2: Division of Vector-Borne Diseases, (C,R,J)

  • Level 3: Arboviral Diseases Branch, (C,R,J,B)
  • Level 3: Bacterial Diseases Branch, (C,R,J,C)
  • Level 3: Dengue Branch, (C,R,J,D)
  • Level 3: Rickettsial Zoonoses Branch, (C,R,J,E)

Level 2: Division of Parasitic Diseases and Malaria, (C,R,K)

  • Level 3: Malaria Branch, (C,R,K,B)
  • Level 3: Parasitic Diseases Branch, (C,R,K,C)
  • Level 3: Entomology Branch, (C,R,K,D)
  • Level 3: Laboratory Science and Diagnostics Branch, (C,R,K,E)

Approved 6/28/2023